We have yet to realize the clinical benefits of combination antifungal therapy, but the
literature is beginning to show the potential positive and negative aspects of this approach …

Invasive fungal infections are a major problem in immunocompromised patients. This has
necessitated an increased interest in the development of new antifungals to treat these life …

The availability of new antifungal agents with novel mechanisms of action and improved
tolerability has widened the possibilities for combination therapy for difficult‐to‐treat …

The cure rate for serious fungal diseases with currently available agents used as
monotherapy is not optimal. The introduction of new classes of antifungal drugs in the last …

The past decade has seen a significant increase in the incidence of invasive fungal
infections. The antifungal armamentarium for the treatment of serious fungal infections …

The availability of new antifungal agents with novel mechanisms of action has stimulated
renewed interest in combination antifungal therapies. In particular, and despite the limited …

The availability of new antifungal agents with unique mechanisms of action and improved
tolerability has widened the possibilities for the use of combination antifungal therapy for …

Invasive mycoses have become an important public health problem as their incidence has
increased dramatically in the last decades, while the discovery of the ideal antifungal agent …

Opportunistic fungi are the most important pathogens in modern world. They are responsible
for severe infections in majority of immunocompromised patients. These microorganisms are …

The management of fungal diseases is challenging. In fact, a number of difficulties have
limited the reliability of the results obtained in clinical studies to date. This article discussed …